Prabhu RV, Prabhu V, Chatra L, Shenai P, Suvarna N, Dandekeri S. Areca nut and its role in oral submucous fibrosis. J Clin Exp Dent. 2014;6(5):e569-75.

 

doi:10.4317/jced.51318

http://dx.doi.org/doi:10.4317/jced.51318

 

References

1. Areca nut. In Wikipedia, the free encyclopedia. Retrieved February 17, 2012, from http://en.wikipedia.org/wiki/Areca_nut                                                        

                                                              

2. Angadi PV, Rao S. Areca nut in pathogenesis of oral submucous fibrosis: revisited. Oral MaxillofacSurg. 2011;15:1-9.

http://dx.doi.org/10.1007/s10006-010-0219-8

PMid:20376683                                                

                                                              

3. Betel chewing. Singapore Infopedia. National Library Singapore. May 5, 1999.                                                            

                                                              

4. Chandra GP, Ray CS. Epidemiology of betel quid usage. AnnAcad Med Singap, 2004;33:31-6.

PMid:15389304                                                

                                                              

5. Paan. In Wikipedia, the free encyclopedia. Retrieved February 24, 2012, from http://en.wikipedia.org/wiki/Paan                                                            

                                                              

6. Sinor PN, Gupta PC, Murti PR. A case control study of oral submucous fibrosis with special reference to the etiologic role of areca nut. J Oral Pathol Med.1990;19:94-8.

http://dx.doi.org/10.1111/j.1600-0714.1990.tb00804.x

PMid:2341977                                                  

                                                              

7. Pindborg JJ, Murti PR, Bhonsle RB, Gupta PC, Daftary DK, Mehta FS. Oral submucous fibrosis as a precancerous condition. Scand J Dent Res,1984;89:270-4.          

PMid:6589738                                   

                                                              

8. Pindborg JJ, Sirasat SM. Oral submucous fibrosis. Oral Surg Oral Med Oral Pathol, 1996;22:746-79.                                                      

                                                              

9. Van Wyk CW, Seedat HA, Phillips VM. Collagen in submucous fibrosis: an electron microscopic study. J Oral Pathol, Med. 1990;19:182-7.

http://dx.doi.org/10.1111/j.1600-0714.1990.tb00821.x

PMid:2366205                                                  

                                                               

10. Pindborg JJ, Bhonsle RB, Murti PR, Gupta PC, Daftary DK, Mehta FS. Incidence and early forms of oralsubmucous fibrosis. Oral surg oral med Oral pathol. 1980;50:40-4.

http://dx.doi.org/10.1016/0030-4220(80)90329-1                                                 

PMid:6930600

                                                              

11. Anbiace N, Tafakhori Z. Early diagnosis of progressive systemic scleosis (sceroderma) from a panoramic view – report of three cases. DMFR. 2011;40:457-62.                  

PMid:21960405                 

                                                              

12. Adyemo TA, Adyemo WL, Akinbami AJ, Akanmu AS. Orofacial manifestations of hematological disorders: Anemia and hemostatic disorders. IJDR. 2011;22:454-61    

PMid:22048588                                

                                                              

13. Jimenez Y, Gavalda C, Carbonell E, Margaix M, Sarrion G. Lichen sclerosus of the oral mucosa: A case report. Med Oral Patol Oral Cir Bucal. 2008;13:E403-6.

PMid:18587302                                                

                                                              

14. Ahmad MS. Epidemiological and etiological study of oral submucous fibrosis among Gutkha chewers of Patna, Bihar, India. J Indian SocPedodPrev Dent. 2006;24:84-8.

http://dx.doi.org/10.4103/0970-4388.26022                                                           

PMid:16823233

                                                              

15. Sharma R, Sunder-Raj S, Mishra G, Reddy YG, Shenava S, Narang P. Prevelance of Oral submucous fibrosis in patients visiting dental College in rural area of Jaipur, Rajasthan. JIOMR. 2014;24:1-4.                                                                                            

16. Rajalalitha P, Vali S. Molecular pathogenesis of oral submucous fibrosis—a collagen metabolic disorder. J Oral Pathol Med. 2005;34:321-8.

http://dx.doi.org/10.1111/j.1600-0714.2005.00325.x

PMid:15946178                                                

                                                              

17. Cox SC, Walker DM. Oral submucous fibrosis: a review. Aust Dent J. 1996;41:294-9

http://dx.doi.org/10.1111/j.1834-7819.1996.tb03136.x                                                        

 PMid: 8961601

                                                              

18. Jeng JH, Chang MC, Hahn LJ. Role of areca nut in betel quid associated chemical carcinogenesis: current awareness and future perspectives. Oral Oncol. 2001;37:477-92.

http://dx.doi.org/10.1016/S1368-8375(01)00003-3                                               

 PMid: 11435174

                                                              

19. Chiang CP, Hsieh RP, Chen TH, Chang YF, Liu BY, Wang JT et al. High incidence of autoantibodies in Taiwanese patients with oral submucous fibrosis. J Oral Pathol Med. 2002;31:402-9.

http://dx.doi.org/10.1034/j.1600-0714.2002.00117.x

PMid:12165058                                                

                                                               

20. Jeng JH, Ho YS, Chan CP, Wang YJ, Hahn LJ, Lei D, et al. Areca nut extract up-regulates prostaglandin production, cyclooxygenase-2 mRNA and protein expression of human oral keratinocytes. Carcinogenesis. 2000;21:1365-70.

http://dx.doi.org/10.1093/carcin/21.7.1365

PMid:10874015                                                

                                                              

21. Tsai CH, Chou MY, Chang YC. The up-regulation of cyclooxygenase-2 expression in human buccal mucosal fibroblasts by arecoline: a possible role in the pathogenesis of oral sub mucous fibrosis. J Oral Pathol Med. 2003;32:146-53.

http://dx.doi.org/10.1034/j.1600-0714.2003.00004.x

PMid:12581384                                                

                                                              

22. Gao Y, Ling T, Wu H. Expression of transforming growth factor beta 1 in keratinocytes of oral submucous fibrosis tissue. Zhonghua Kou Qiang Yi XueZaZhi (Chinese). 1997;32:239-41.           

 PMid: 10680515                              

                                                              

23. Vindevoghel L, Kon A, Lechleider RJ, Uitto J, Roberts AB, Mauviel A. Smad-dependent transcriptional activation of human type VII collagen gene (COL7A1) promoter by transforming growth factor-b. J BiolChem, 1998;273:13053-7.

http://dx.doi.org/10.1074/jbc.273.21.13053

PMid:9582342                                                  

                                                               

24. Rucker RB, Romero-Chapman N, Wong T, Lee J, Steinberg FM, McGee C, Clegg MS,
Reiser K, Kosonen T, Uriu-Hare JY, Murphy J, Keen CL. Modulation of lysyl oxidase by dietary copper in rats. J Nutr. 1996;126:51-60.

PMid:8558325                                                  

                                                              

25. Panchenko MV, Stetler-Stevenson WG, Trubetskoy OV, Gacheru SN, Kagan HM. Metalloproteinase activity secreted by fibrogenic cells in the processing of prolysyl oxidase. J BiolChem. 1996;271:7113-9.

http://dx.doi.org/10.1074/jbc.271.12.7113

PMid:8636146                                                  

                                                              

26. Kosonen T, Uriu-Hare JY, Clegg MS, Keen CL, Rucker RB. Incorporation of copper into lysyl oxidase. Biochem J. 1997;327:283-9.

PMid:9355764 PMCid:PMC1218792                                                           

                                                              

27. Smith-Mungo LI, Kagan HM. Lysyl oxidase: properties, regulation and multiple functions in biology. Matrix Biol. 1998;16:387-98.

http://dx.doi.org/10.1016/S0945-053X(98)90012-9

PMid:9524359                                   

                                                              

28. Tang C, Klinman JP. The catalytic function of bovine lysyl oxidase in the absence of copper. J BiolChem. 2001;276:30575-8.

http://dx.doi.org/10.1074/jbc.C100138200

PMid:11395477                                                

                                                              

29. Trivedy C, Meghji S, Warnakulasuriya KA, Johnson NW, Harris M. Copper stimulates human oral fibroblasts in vitro: a role in the pathogenesis of oral submucous fibrosis. J Oral Pathol of Med. 2001;30:465-70.

http://dx.doi.org/10.1034/j.1600-0714.2001.030008465.x                                                  

PMid:11545237

                                                              

30. Trivedy CR, Warnakulasuriya KA, Peters TJ, Senkus R, Hazarey VK, Johnson NW. Raised tissue copper levels in oral submucous fibrosis. J Oral Pathol Med. 2000;29:241-8.

http://dx.doi.org/10.1034/j.1600-0714.2000.290601.x

PMid:10890553                                                

                                                              

31. DiSilvestro RA, Harris ED. Evaluation of catechin action on lysyl oxidase activity in aortic tissue. BiochemPharmacol. 1983;32:343-6.

http://dx.doi.org/10.1016/0006-2952(83)90565-8                  

PMid:6135426                   

                                                               

32. Cetta G, Gerzeli G, Quartieri A, Castellani AA. Protective effect of flavonoids on the collagen of lathyritic rats. Experientia, 1971;27:1046-8.

http://dx.doi.org/10.1007/BF02138872

PMid:5116128                                                  

                                                              

33. Nagase H, Woessner Jr JF. Matrix metalloproteinases. J BiolChem 1999;274:21491-4.

http://dx.doi.org/10.1074/jbc.274.31.21491

PMid:10419448                                                

                                                              

34. Shieh DH, Chiang LC, Shieh TY. Augmented mRNA expression of tissue inhibitor of metalloproteinase-1 in buccal mucosal fibroblasts by arecoline and safrole as a possible pathogenesis for oral submucous fibrosis. Oral Oncol. 2003;39:728-35.

http://dx.doi.org/10.1016/S1368-8375(03)00101-5                                               

 PMid: 12907213

                                                              

35. Chang YC, Yang SF, Tai KW, Chou MY, Hsieh YS. Increased tissue inhibitor of metalloproteinase-1 expression and inhibition of gelatinase: A activity in buccal mucosal fibroblasts by arecoline as possible mechanisms for oral submucous fibrosis. Oral Oncol. 2002;38:195-200.

http://dx.doi.org/10.1016/S1368-8375(01)00045-8

PMid: 11854068                               

                                                              

36. Andreasen PA, Egelund R, Petersen HH. The plasminogen activation system in tumor growth, invasion, and metastasis. Cell Mol Life Sci. 2000;57:25-40.

http://dx.doi.org/10.1007/s000180050497

PMid:10949579                                                

                                                              

37. Ellis V, Wun TC, Behrendt N, Ronne E, Dano K. Inhibition of receptor-bound urokinase by plasminogen activator inhibitors. J BiolChem. 1990;265:9904-8.

PMid:2161846                                                  

                                                               

38. Tietze L, Elbrecht A, Schauerte C, Klosterhalfen B, Amo-Takyi B, Gehlen J,
Winkeltau G, Mittermayer C, Handt S. Modulation of pro- and antifibrinolytic properties of human peritoneal mesothelial cells by transforming growth factor beta1 (TGF-beta1), tumor necrosis factor alpha (TNF-alpha) and interleukin 1beta (IL-1beta). Thromb Haemostasis. 1998;79:362-70.

PMid:9493592                                                  

                                                              

39.Tsai CC, Ma RH, Shieh TY. Deficiency in collagen and fibronectin phagocytosis by human buccal mucosa fibroblasts in vitro as a possible mechanism for oral submucous fibrosis. J Oral Pathol Med.1999;28:59-63.

http://dx.doi.org/10.1111/j.1600-0714.1999.tb01997.x

PMid:9950251                                                  

                                                              

40. Shieh DH, Chiang LC, Lee CH, Yang YH, Shieh TY. Effects of arecoline, saffrole and nicotine on collagen phagocytosis by human buccal mucosal fibroblasts as a possible mechanism for oral submucous fibrosis. J Oral Pathol Med. 2004;33:581-7.

http://dx.doi.org/10.1111/j.1600-0714.2004.00229.x

PMid:15357680